Combination treatment using exendins and thiazolidinediones
OwnerLotte Kaudseninventor
Life of this patent
Estimating the term…
Abstract
The present invention relates to methods for treatment and/or prevention of diabetes and diabetes related diseases. More specifically, the methods and uses of the invention pertains to administration of an exendin-4 compound in combination with administration of a thiazolidinedione insulin sensitizer.
Claims25
A method for treating diabetes or diabetes related disease in a subject in need of such treatment, said method comprising administering to said subject an effective amount of an exendin-4 compound and an effective amount of a thiazolidinedione insulin sensitizer.
A pharmaceutical composition comprising an exendin-4 compound, a thiazolidinedione and a pharmaceutically acceptable preservative.
A method for increasing the number or size of beta-cells in a subject or stimulating beta-cell proliferation in a subject, said method comprising administering an effective amount of an exendin-4 compound and an effective amount of a thiazolidinedione insulin sensitizer to said subject.
Dependencies are inferred from the claim text.